Video Library

Search the Video Library

Filter by Date

Displaying Results 1 - 15 of 48

All of us at the Global Resource for Advancing Cancer Education are very excited to introduce our newest project - the GRACE Spanish Lung Cancer Library. This collection of videos with our Spanish speaking faculty will discuss the basics of lung cancer for Spanish speaking patients and caregivers

¿Cómo los subtipos histológicos del cáncer pulmonar de células no pequeñas alteran las recomendaciones en el estadio avanzado?

For our third video in the GRACE Spanish Lung Cancer Library, Antonio Calles, MD, Medical Oncologist, Thoracic Oncology Program, Hospital General Universitario, Gregorio Marraron, Madrid, Spain joined GRACE to discuss how NSCLC subtype (histology) can alter chemotherapy recommendations in advanced

¿Cuál es el rol de Avastin (bevacizumab) en el tratamiento del cáncer de pulmón de células no pequeñas en la actualidad?

For our 4th video in the GRACE Spanish Lung Cancer Library, Antonio Calles, MD joined GRACE to discuss what the role of Avastin (bevacizumab) is in treating advanced NSCLC today.

¿Cuál es el tratamiento más apropiado para pacientes mayores con cáncer pulmonar de células no pequeñas avanzado? ¿La edad altera las recomendaciones?

For our 5th video in the GRACE Spanish Lung Cancer Library, Antonio Calles, MD joined GRACE to discuss the most appropriate treatment for elderly patients with advanced NSCLC, and whether age alters the recommendations.

¿Cuál es la terapia de mantenimiento? Y ¿Por qué se recomienda en el cáncer pulmonar de células no pequeñas en etapa avanzada?

For our 6th video in the GRACE Spanish Lung Cancer Library, Antonio Calles, MD joined GRACE to discuss what is maintenance therapy and why it would be recommended in advanced NSCLC.

¿Cuál es el mejor tratamiento para pacientes débiles con cáncer pulmonar de células no pequeñas en estado avanzado?

For our 7th video in the GRACE Spanish Lung Cancer Library, Antonio Calles, MD joined GRACE to discuss the best treatment for frail patients with advanced NSCLC.

Factores de riesgo del cáncer de pulmón

For our 8th video in the GRACE Spanish Lung Cancer Library, Brian Hunis, MD joined GRACE to discuss the risk factors for lung cancer.

Los pros y los contras de la detencion del cancer de pulmón

For our 9th video in the GRACE Spanish Lung Cancer Library, Brian Hunis, MD joined GRACE to discuss the pros and cons of lung cancer screening.

¿Cómo se realiza el diagnóstico de cancer de pulmón?

For our 10th video in the GRACE Spanish Lung Cancer Library, Brian Hunis, MD joined GRACE to discuss how a lung cancer diagnosis is made.

Subtipos del Cancer de Pulmón

For our 11th video in the GRACE Spanish Lung Cancer Library, Brian Hunis, MD joined GRACE to discuss lung cancer subtypes.

¿Qué es una tomografía por emisión de positrones (PET)?

For our 12th video in the GRACE Spanish Lung Cancer Library, Brian Hunis, MD joined GRACE to discuss what a PET scan is.

Las Etapas en el Cáncer de Pulmón

For our 13th video in the GRACE Spanish Lung Cancer Library, Brian Hunis, MD joined GRACE to discuss the stages of lung cancer.

Terapia de primera línea para pacientes con cáncer pulmonar de células no pequeñas que presentan la cinasa de linfoma anaplásico (CLA) positiva.

For our 17th video in the GRACE Spanish Lung Cancer Library, Brian Hunis, MD joined GRACE to discuss first line therapy for NSCLC patients that have anaplastic lymphoma kinase (ALK) positive.

Resistencia adquirida a las terapias dirigidas: Biología y diferentes patrones clínicos.

For our 18th video in the GRACE Spanish Lung Cancer Library, Brian Hunis, MD joined GRACE to discuss acquired resistance to targeted therapies: biology and different clinical patterns.

Terapia de segunda línea para pacientes con cáncer pulmonar de células no pequeñas y con la cinasa de linfoma anaplásico (CLA) positiva.

For our 19th video in the GRACE Spanish Lung Cancer Library, Dr. Brian Hunis, joined GRACE to discuss the basics of Lung Cancer for Spanish-speaking patients and caregivers. In this video Dr. Hunis discusses second line therapy for NSCLC patients who are ALK positive.